Inflammation in neurological and psychiatric diseases

Parto S. Khansari, B. Sperlágh

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

In recent years, compelling evidence suggests that inflammation plays a critical role in the pathology of a vast number of neurological diseases such as stroke, Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis as well as neuropsychiatric diseases such as major depression and schizophrenia. Despite emerging evidence in human and animal models alike, modulating inflammatory responses have yet to be proven as an effective treatment to prevent or delay the progression of these diseases. The primary focus of this special edition is to highlight some of our current findings on the complexities of targeting neuroinflammation as a novel therapy, and its role in neurological and psychiatric disorders.

Original languageEnglish
Pages (from-to)103-107
Number of pages5
JournalInflammopharmacology
Volume20
Issue number3
DOIs
Publication statusPublished - Jun 2012

Fingerprint

Psychiatry
Inflammation
Amyotrophic Lateral Sclerosis
Nervous System Diseases
Parkinson Disease
Disease Progression
Schizophrenia
Alzheimer Disease
Animal Models
Stroke
Depression
Pathology
Therapeutics

Keywords

  • Acute neurological diseases
  • Alzheimer's disease
  • Astrocytes
  • Chronic neurological diseases
  • Major depression
  • Microglia
  • Neuroinflammation
  • NSAIDs
  • Parkinson's disease
  • Pro-inflammatory cytokines
  • Psychiatric diseases
  • Schizophrenia
  • Stroke

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Immunology

Cite this

Inflammation in neurological and psychiatric diseases. / Khansari, Parto S.; Sperlágh, B.

In: Inflammopharmacology, Vol. 20, No. 3, 06.2012, p. 103-107.

Research output: Contribution to journalArticle

Khansari, Parto S. ; Sperlágh, B. / Inflammation in neurological and psychiatric diseases. In: Inflammopharmacology. 2012 ; Vol. 20, No. 3. pp. 103-107.
@article{3a37d2b6845e42abb0a8e59c3e02ca17,
title = "Inflammation in neurological and psychiatric diseases",
abstract = "In recent years, compelling evidence suggests that inflammation plays a critical role in the pathology of a vast number of neurological diseases such as stroke, Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis as well as neuropsychiatric diseases such as major depression and schizophrenia. Despite emerging evidence in human and animal models alike, modulating inflammatory responses have yet to be proven as an effective treatment to prevent or delay the progression of these diseases. The primary focus of this special edition is to highlight some of our current findings on the complexities of targeting neuroinflammation as a novel therapy, and its role in neurological and psychiatric disorders.",
keywords = "Acute neurological diseases, Alzheimer's disease, Astrocytes, Chronic neurological diseases, Major depression, Microglia, Neuroinflammation, NSAIDs, Parkinson's disease, Pro-inflammatory cytokines, Psychiatric diseases, Schizophrenia, Stroke",
author = "Khansari, {Parto S.} and B. Sperl{\'a}gh",
year = "2012",
month = "6",
doi = "10.1007/s10787-012-0124-x",
language = "English",
volume = "20",
pages = "103--107",
journal = "Inflammopharmacology",
issn = "0925-4692",
publisher = "Birkhauser Verlag Basel",
number = "3",

}

TY - JOUR

T1 - Inflammation in neurological and psychiatric diseases

AU - Khansari, Parto S.

AU - Sperlágh, B.

PY - 2012/6

Y1 - 2012/6

N2 - In recent years, compelling evidence suggests that inflammation plays a critical role in the pathology of a vast number of neurological diseases such as stroke, Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis as well as neuropsychiatric diseases such as major depression and schizophrenia. Despite emerging evidence in human and animal models alike, modulating inflammatory responses have yet to be proven as an effective treatment to prevent or delay the progression of these diseases. The primary focus of this special edition is to highlight some of our current findings on the complexities of targeting neuroinflammation as a novel therapy, and its role in neurological and psychiatric disorders.

AB - In recent years, compelling evidence suggests that inflammation plays a critical role in the pathology of a vast number of neurological diseases such as stroke, Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis as well as neuropsychiatric diseases such as major depression and schizophrenia. Despite emerging evidence in human and animal models alike, modulating inflammatory responses have yet to be proven as an effective treatment to prevent or delay the progression of these diseases. The primary focus of this special edition is to highlight some of our current findings on the complexities of targeting neuroinflammation as a novel therapy, and its role in neurological and psychiatric disorders.

KW - Acute neurological diseases

KW - Alzheimer's disease

KW - Astrocytes

KW - Chronic neurological diseases

KW - Major depression

KW - Microglia

KW - Neuroinflammation

KW - NSAIDs

KW - Parkinson's disease

KW - Pro-inflammatory cytokines

KW - Psychiatric diseases

KW - Schizophrenia

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=84862978546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862978546&partnerID=8YFLogxK

U2 - 10.1007/s10787-012-0124-x

DO - 10.1007/s10787-012-0124-x

M3 - Article

VL - 20

SP - 103

EP - 107

JO - Inflammopharmacology

JF - Inflammopharmacology

SN - 0925-4692

IS - 3

ER -